Clinical trial
Danish Hypertension Prevention Project - DHYPP
NCT00150631 · Karin Skov, Other · Unknown status
Key facts
| NCT number | NCT00150631 |
|---|---|
| Title | Danish Hypertension Prevention Project - DHYPP |
| Official title | Danish Hypertension Prevention Project |
| Lead sponsor | Karin Skov, Other |
| Collaborators | University of Aarhus AstraZeneca Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Candesartan |
| Enrollment | 100 |
| Start date | Nov 1, 2000 |
| Primary completion | Jan 1, 2004 |
| Completion | Dec 1, 2014 |
| First posted | Sep 8, 2005 |
| Last update posted | Nov 26, 2014 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: